VAST – having promised no more death spirals and then done one with no conversion notice within 30 days…….. WTF, Nomad Fatty?
Tom Winnifrith Bearcast: If First Derivatives only wants questions about how big its CEO's cock is I have a nasty surprise for it
Cloudcall – 2018 ‘a standout year in terms of innovation, platform investment and sales & marketing capabilities’… so cash burn?
Published 5 days ago
I start with a few thoughts on this, the birthday, of Martin Luther King. Then onto the two disasters for the £37 million smug bastard, Neil "nomates" Woodford: Netscientific (NSCI) and Provident Financial (PFG). I look at Big Sofa (BST) and Yourgene (YGEN) , my nap for Q1, then onto Victoria Carpets (VCP) and finally a detailed laook at the fraud that is Eden Research (EDEN).
Published 9 days ago
Over almost fifty years Nigel Wray's record of making money from value investing is almost unmatched on this side of the Pond. That is why he is referrred to as Britain's Buffett. So what makes him back a stock? How can you invest like Britain's Buffett
Published 45 days ago
There is, for we long suffering shareholders, light at the end of the tunnel though a first read of results from Yourgene (YGEN) for the six months to 30 September 2018 does not exactly bring a warm feeling. But there is a new CEO, Lyn Rees, and he seems to have a clue. Of course the Illumina patent issue was only settled during this period and that should be born in mind. To the numbers…
Published 48 days ago
Gabriel's dossier should appear here 2.15 PM London time. It is explosive. In today's podcast I discuss Telit (TCM) and shamed FinnCrap, Halosource (HAL) and hapless Neil Woodford, Audioboom (BOOM) and a backfiring spoof, Tomco (TCM), Yourgene (YGEN) and the weather here in Greece as the olive harvest draws to a close.
Published 227 days ago
The rehabilitation of Premaitha Health (NIPT) continues. The latest news is from India where there is not even a whiff of a patent challenge from Illumina and where our boys have signed a 3-year agreement with one of the most advanced clinical laboratory groups in the country to provide a bespoke, high quality and scaleable NIPT solution.